Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic and Influenza Vaccination for ILI Prevention in the Elderly
NCT03695432Phase 4Completed
- Sponsor
- Universitas Indonesia
- Start
- Oct 2014
- Primary completion
- Apr 2015
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of influenza virus vaccine (Flubio) and Lacidofil in influenza-like illness (ILI) (4 arms), sponsored by Universitas Indonesia. Primary endpoint: Percentage enhancement of the immune response to flubio vaccine and probiotic compared to placebo at 6 months. Started Oct 2014; status: completed.
02
Drugs
influenza virus vaccine (Flubio)Lacidofil
03
Conditions
influenza-like illness (ILI)
Beyond the preview
Go deeper on NCT03695432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03695432.